Rekvina Laboratories Ltd

NSE: VINRKLB · BSE: 526075 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹51.51
Market cap: ₹31.05 Cr
Revenue (annual): ₹1.27 Cr
Net profit (annual): ₹-0.25 Cr
P/E (TTM): -91.4×Sector 47.3×
Promoter holding: 77.00%+35.70% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Management Change 3 Financial Results 3 Annual General Meeting 3 Open Offer 2 Board Meeting Date 2 Price Movement Clarification 1 Merger & Restructuring 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

13 Aug 2026 15:48 IST BSE

Financial Results

Rekvina Laboratories Q1 FY27 Results: Net Loss of ₹0.1 Cr

Rekvina Laboratories Ltd reported revenue from operations of ₹0.7 Cr and a net loss of ₹0.1 Cr for Q1 FY27.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗

21 May 2026 20:15 IST BSE

Financial Results

Rekvina Laboratories Q4 FY26 Results: Net Loss of ₹0.1 Cr

Rekvina Laboratories Ltd reported revenue from operations of ₹0.7 Cr and a net loss of ₹0.1 Cr for Q4 FY26.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗

21 May 2026 20:14 IST BSE

Financial Results

Rekvina Laboratories Financial Results

Rekvina Laboratories reported audited financial results for the year ended March 31, 2026. The company also approved an authorized capital increase and potential acquisition.

Read the filing ↗